ELI LILLY & Co — Director's Dealing 2012

Feb 3, 2012

SEC Form 4/A — Form 4/A

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2012-01-26

Reporting Person: Mahony Susan (SVP & Pres., Lilly Oncology)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-01-26	Common Stock	A	1285	$39.44	Acquired	4561	Indirect

Footnotes

F1: This amendment is being filed to correct the number of securities reported as acquired on the original Form 4 filed on 1/30/2012; 82 shares were inadvertently omitted from the total.

F2: Reporting person disclaims beneficial ownership of these shares.